Pharmaceutical Community News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FreightWeek - Insights on sustainable business practices for the global logistics industry

The javelin on the left, this is the stinger on the right, tanks and aircraft, if they come in too low, they're being shot down. anything on the ground is being eaten up by small squads. it's an almost impossible fight over time for the russians. >> that's what everybody seems to be coming to that conclusion. and yet they have not -- they keep banging their head against this brick wall. courtney and clint, thank you. i'm joined by the ceo of the country's largest pharmaceutical community, amid this russian assault in kyiv he's been housing employees, has families in his facilities, basically i...

Basically. and cities around the country, basically in a lot of northern cities, it was because african-americans who had participated in the great migration were competing for and winning jobs and that's the underlying tension that led to these riots that were like eastern europe pogroms. therm deadly and terrible hi violence. and the other reason was that african-american businesses were competing successfully against white mississippi and atlanta in 1906, there was a deadly white race riot against, in which the white business district downtown was smashed up and destroyed and eventually, af...

Vaccine, you may -- mika talks about long runways, you may have a very long runway as far as either immunity or safety from covid and its variants. >> that's right. we think that this virus probably sits somewhere in between seasonal coronaviruses and sars 1, which you referenced. the immunity from sars 1 was very durable. the immunity we get from seasonal coronaviruses doesn't last long. it lasts a year. we think that the immunity that's induced here will probably last longer than seasonal coronavirus, probably not as long as sars 1. but tl different correlates for immunity. you could still h...

There's not going to be a situation like we have with influenza, where all of a sudden a new mutation arises and the vaccine isn't effective at all. i think we'll see variants that emerge where the vaccines weren't as effective against the origin form of the virus. the vaccine doesn't seem to be as effective as it was against the origin wuhan strain of the virus. sometimes you get a phenomenon in virology where you can have two mutations that individually aren't really that concerning in terms of their ability to defeat the vaccine. but when you combine those two mutations in a new strain, sud...